Literature DB >> 23572037

Exacerbation of latent lupus: is the culprit acid-fast bacilli or antitubercular therapy?

Harpreet Singh1, Sucharita Ray, Maneet Kaur, Vikas Gupta, Harish Kumar, Paulomi Talapatra, Rekha Mathur, Suvrat Arya, Naveen Ghangas.   

Abstract

Typical as well as atypical presentations of systemic lupus erythematosus are being increasingly recognized due to improved diagnostic methods. In a tuberculosis-endemic country like India, it was traditionally believed that the occurrence of tuberculosis in lupus was due to the chronic immunosuppression caused by lupus or because of the use of steroids or isoniazid-induced lupus. Increasingly several patients with no recorded predisposition to lupus with a history of treatment for tuberculosis are coming with evidence of systemic lupus erythematosus rather than a drug-limited story. Whether the development of an autoimmune state is a mere conjecture or the presence of acid-fast bacilli in the body for a prolonged duration causes complex antigenic interactions leading to an antigenic response needs to be looked into. We present a report of three such patients and review the pathogenetic interactions that could possibly explain the role of mycobacterial antigens as a putative antigen in the pathogenesis of lupus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572037     DOI: 10.1007/s10067-013-2250-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Mycobacterium tuberculosis in the aetiology of sarcoidosis.

Authors:  J G SCADDING
Journal:  Br Med J       Date:  1960-12-03

2.  High risk of tuberculosis in systemic lupus erythematosus?

Authors:  J G Erdozain; G Ruiz-Irastorza; M V Egurbide; A Martinez-Berriotxoa; C Aguirre
Journal:  Lupus       Date:  2006       Impact factor: 2.911

3.  Tuberculosis in patients with systemic lupus erythematosus.

Authors:  C Balakrishnan; G Mangat; G Mittal; V R Joshi
Journal:  J Assoc Physicians India       Date:  1998-08

Review 4.  Drug-induced lupus: an update.

Authors:  S Vasoo
Journal:  Lupus       Date:  2006       Impact factor: 2.911

5.  Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis.

Authors:  R Gruber; S Lederer; U Bechtel; S Lob; G Riethmüller; H E Feucht
Journal:  Int Arch Allergy Immunol       Date:  1996-05       Impact factor: 2.749

6.  Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization.

Authors:  M Sayarlioglu; M Inanc; S Kamali; A Cefle; O Karaman; A Gul; L Ocal; O Aral; M Konice
Journal:  Lupus       Date:  2004       Impact factor: 2.911

7.  Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.

Authors:  A Ueki; Y Isozaki; A Tomokuni; T Hatayama; H Ueki; M Kusaka; M Shiwa; H Arikuni; T Takeshita; K Morimoto
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

  7 in total
  1 in total

1.  IL-17 Production of Neutrophils Enhances Antibacteria Ability but Promotes Arthritis Development During Mycobacterium tuberculosis Infection.

Authors:  Shengfeng Hu; Wenting He; Xialin Du; Jiahui Yang; Qian Wen; Xiao-Ping Zhong; Li Ma
Journal:  EBioMedicine       Date:  2017-08-09       Impact factor: 8.143

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.